1. Home
  2. BFRI vs ATPC Comparison

BFRI vs ATPC Comparison

Compare BFRI & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFRI
  • ATPC
  • Stock Information
  • Founded
  • BFRI 1997
  • ATPC 2016
  • Country
  • BFRI United States
  • ATPC Malaysia
  • Employees
  • BFRI N/A
  • ATPC N/A
  • Industry
  • BFRI Biotechnology: Pharmaceutical Preparations
  • ATPC Medical/Nursing Services
  • Sector
  • BFRI Health Care
  • ATPC Health Care
  • Exchange
  • BFRI Nasdaq
  • ATPC Nasdaq
  • Market Cap
  • BFRI 6.2M
  • ATPC 6.1M
  • IPO Year
  • BFRI 2021
  • ATPC N/A
  • Fundamental
  • Price
  • BFRI $0.98
  • ATPC $1.19
  • Analyst Decision
  • BFRI Strong Buy
  • ATPC
  • Analyst Count
  • BFRI 1
  • ATPC 0
  • Target Price
  • BFRI $7.00
  • ATPC N/A
  • AVG Volume (30 Days)
  • BFRI 990.2K
  • ATPC 246.3K
  • Earning Date
  • BFRI 11-13-2024
  • ATPC 02-15-2025
  • Dividend Yield
  • BFRI N/A
  • ATPC N/A
  • EPS Growth
  • BFRI N/A
  • ATPC N/A
  • EPS
  • BFRI N/A
  • ATPC N/A
  • Revenue
  • BFRI $35,358,000.00
  • ATPC $1,354,042.00
  • Revenue This Year
  • BFRI $17.69
  • ATPC N/A
  • Revenue Next Year
  • BFRI $19.71
  • ATPC N/A
  • P/E Ratio
  • BFRI N/A
  • ATPC N/A
  • Revenue Growth
  • BFRI 5.17
  • ATPC N/A
  • 52 Week Low
  • BFRI $0.61
  • ATPC $1.10
  • 52 Week High
  • BFRI $3.90
  • ATPC $19.60
  • Technical
  • Relative Strength Index (RSI)
  • BFRI 52.63
  • ATPC 45.17
  • Support Level
  • BFRI $0.94
  • ATPC $1.10
  • Resistance Level
  • BFRI $1.06
  • ATPC $1.56
  • Average True Range (ATR)
  • BFRI 0.12
  • ATPC 0.15
  • MACD
  • BFRI -0.01
  • ATPC -0.00
  • Stochastic Oscillator
  • BFRI 28.89
  • ATPC 47.04

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.

Share on Social Networks: